Results 161 to 170 of about 271,461 (267)
PRISMA study flow diagram. ABSTRACT Introduction Advances in HIV management have transformed HIV into a chronic condition, resulting in improved prognosis and increased survival among people living with HIV (PLWH). Traditional risk factors for metabolic dysfunction‐associated steatotic liver disease (MASLD)—including dyslipidemia—are prevalent in PLWH.
Yovita Hartantri +6 more
wiley +1 more source
Unveiling hepatitis E virus diversity in Sudan's internally displaced populations: a molecular epidemiology approach. [PDF]
Osman HA +7 more
europepmc +1 more source
Conformational Trajectory of the Molecular Chameleon Grazoprevir from Formulation to Target‐Bound
ABSTRACT Macrocycles represent a promising class of beyond‐rule‐of‐5 (bRo5) therapeutics, capable of targeting proteins traditionally considered undruggable by conventional small molecules. Macrocycles exhibit intrinsic flexibility and often display a “chameleon‐like” ability to adapt to their environment, thereby enhancing their oral bioavailability ...
Lianne H. E. Wieske +5 more
wiley +1 more source
Zoonotic hepatitis E virus spreads through environmental routes in pig herds - A phylodynamic analysis. [PDF]
Meester M +11 more
europepmc +1 more source
Prevalences of hepatitis A, B, C and E viruses in Behçet's disease [PDF]
Kenan Aksu +7 more
openalex +1 more source
Abstract Bepirovirsen, an antisense oligonucleotide in development for the treatment of chronic hepatitis B virus (HBV) infection, is administered from glass vials as a subcutaneous (SC) injection by healthcare professionals (HCPs). A ready‐to‐use prefilled syringe (PFS) assembled with a safety syringe device (SSD) has been developed to make ...
Amir S. Youssef +15 more
wiley +1 more source
A Rare Case of Triple Infection with Leptospira, Hepatitis A Virus, and Hepatitis E Virus. [PDF]
Petrakis V +4 more
europepmc +1 more source
Abstract Votoplam is a novel, orally bioavailable, small molecule HTT gene splicing modifier that is being developed for the treatment of Huntington's disease. This was a single dose, open‐label, two‐period, crossover food effect study that evaluated the effect of high‐ and low‐fat meals on 20 mg votoplam in healthy participants. There was a washout of
Lucy Lee +5 more
wiley +1 more source

